Cases & Deals

Maverick Capital affiliates participate in Series C financing round by Spiracur

Clients Maverick Capital Ltd.

Jones Day advised affiliates of Maverick Capital Ltd. in connection with their purchase of Series C Preferred Stock in a private placement by Spiracur, Inc., a medical device company focused on the development of innovative wound healing technologies. Co-investors include De Novo Ventures, Kleiner Perkins Caufield & Byers, New Leaf Venture Partners, and Pinnacle Ventures, L.L.C.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.